CONMED
CNMD
239 hedge funds and large institutions have $4.05B invested in CONMED in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 83 increasing their positions, 98 reducing their positions, and 29 closing their positions.
17% more capital invested
Capital invested by funds: $3.46B → $4.05B (+$594M)
0.5% less ownership
Funds ownership: 107.78% → 107.28% (-0.5%)
4% less funds holding
Funds holding: 249 → 239 (-10)
15% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 98
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
74% less call options, than puts
Call options by funds: $6.49M | Put options by funds: $24.6M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$42.2M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$39.7M |
| 3 |
BlackRock
New York
|
+$28.1M |
| 4 |
JP Morgan Chase
New York
|
+$28M |
| 5 |
HM
HealthCor Management
New York
|
+$21.3M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$34.8M |
| 2 |
Millennium Management
New York
|
-$29.4M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.7M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
-$17M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$15.8M |
CNMD Hedge Fund Activity: Q1 2021 in Review
239 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2021, worth a combined $4.05B — up 17% from $3.46B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CNMD and 21 opened new positions — a net loss of 8 holders — while 98 trimmed existing stakes and 83 added.
The largest buyer was Loomis, Sayles & Company, adding an estimated $42.2M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $34.8M sold.
- 239 institutional investors held CONMED (CNMD) as of Q1 2021, down from 249 in Q4 2020.
- Funds reported $4.05B of CONMED stock for Q1 2021, up 17% quarter-over-quarter.
- 21 funds opened new CONMED positions in Q1 2021 and 29 closed out, a net change of -8 holders.
- The largest CONMED buyer in Q1 2021 was Loomis, Sayles & Company, an estimated $42.2M added.
- The largest CONMED seller in Q1 2021 was Scopia Capital Management, an estimated $34.8M sold.
Based on aggregated 13F filings for Q1 2021.